Is Seleniso produced in India? Is it a good buy?

Selinexor (Selinexor), known as the pioneer of "nuclear export inhibitors", is unique in the field of treating myeloma. Its mechanism of action is to effectively prevent cancer cells from emitting tumor suppressor proteins that protect cells from cancer. This drug is a prescription drug and must be used under the guidance of a doctor. It is understood that India does not produce the original drug or generic version of Selinisol. Common generic drugs on the market mainly come from manufacturers such as Lucius Pharmaceuticals and Daxiong Pharmaceuticals in Laos.

Selinesol has shown excellent results in the treatment of multiple myeloma. When used in combination with bortezomib and dexamethasone, it is effective in patients who have experienced poor response to at least one treatment. In addition, the combination of selinesol and dexamethasone has emerged as a powerful treatment option for patients with multiple myeloma who have relapsed or failed to respond to treatment. These patients have often gone through at least four rounds of treatment and have failed to respond to multiple other cancer drugs. Not only that, selinesol has also shown its unique efficacy in the treatment of certain diffuse large B-cell lymphoma (DLBCL) that has relapsed or failed to respond to treatment.

In terms of price, Seleniso’s original drug is sold in markets in many countries around the world, but the price is relatively high. In China, a box of Seleniso may cost more than 20,000 yuan, while in overseas markets, the price may even soar to more than 100,000 yuan. In comparison, the price of generic drugs is much more affordable, with each box selling for about 2,000 to 4,000 yuan, but the specific price is still affected by exchange rate fluctuations. Whether they are original drugs or generic drugs, their pharmaceutical ingredients are basically the same, and the main differences are price and specifications.